Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05040711 · ClinicalTrials.gov registry record · NA

mHealth Mindfulness With Patients With Serious Illness and Their Caregivers

A NA study of Anxiety and Caregiver Stress Syndrome, sponsored by Rutgers, The State University of New Jersey.

Recruiting
Registry status
NA
Development phase
162
Enrollment target
3
Study locations

NCT05040711: Recruiting NA study of Anxiety and Caregiver Stress Syndrome, sponsored by Rutgers, The State University of New Jersey.

NCT05040711 is a NA study of Anxiety and Caregiver Stress Syndrome that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 162 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (63% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05040711, a NA study of Anxiety and Caregiver Stress Syndrome, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.

RECRUITING
Registry status
NA
Development phase
162 participants
Enrollment target
3
Study locations

Study Summary

Older adults with serious illness and their caregivers have high rates of anxiety and limited access to effective, non-pharmacological treatments. A recent National Academy of Medicine report recommended increased emphasis on disseminating and implementing evidence-based psychotherapies in order to have maximal public health impact. Through this work, I will identify a sustainable and potentially scalable dyadic intervention and delivery model to manage symptoms of anxiety in older adults with serious illness and their caregivers in primary care.

Primary Outcome

Anxiety scale with range from 0-21 with higher scores denoting highest anxiety

Interventions

  • BEHAVIORAL Active Comparator
  • BEHAVIORAL Mindfulness Coach

Study Locations (3)

New Jersey

  • RWJ Barnabas Outpatient Geriatric Clinics - Livingston
  • RWJB Outpatient Geriatrics - Monroe
  • Cancer Institute of New Jersey - New Brunswick

Trial Details

FieldValue
Enrollment Target 162 participants
Start Date 2022-04-26
Est. Completion 2026-10-01
Phase NA

What NCT05040711 shows while recruiting

NCT05040711 is an interventional study that assigns participants to a tested intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (63% lower).

The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Active Comparator is the first listed.

NCT05040711 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT05040711 about?

NCT05040711 is a clinical study titled "mHealth Mindfulness With Patients With Serious Illness and Their Caregivers". Older adults with serious illness and their caregivers have high rates of anxiety and limited access to effective, non-pharmacological treatments. A recent National Academy of Medicine report recommended increased emphasis on disseminating and implementing evidence-based psychotherapies in order to ...

What is the current status of trial NCT05040711?

This trial is currently recruiting. It is a NA study. The enrollment target is 162 participants. The study started on 2022-04-26. Estimated completion is 2026-10-01.

What conditions does trial NCT05040711 study?

This clinical trial studies the following conditions: Anxiety, Caregiver Stress Syndrome.

What interventions are being tested in trial NCT05040711?

The interventions under investigation include: Active Comparator (BEHAVIORAL), Mindfulness Coach (BEHAVIORAL).

Who is sponsoring clinical trial NCT05040711?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05040711 being conducted?

This trial has 3 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05040711's enrollment target sits among peer trials

162 103rd of 364 higher than 262 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02347111 · 162 participants · Phase 4

    Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation

  • NCT02610426 · 162 participants

    Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer

  • NCT05514717 · 162 participants · Phase 1

    A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2

  • NCT05737693 · 162 participants · Phase 2

    Enhancing Week-long Psychological Treatment for PTSD With Ketamine

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05040711, the US trial registry maintained by the National Library of Medicine. NCT05040711 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.